documents: FDA-2020-N-1082-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-1082-0002 | FDA | FDA-2020-N-1082 | Reference 5 - Aisyah et al Journal Viral Hep 2018 re Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests | Supporting & Related Material | Background Material | 2020-04-02T04:00:00Z | 2020 | 4 | 2020-04-02T13:16:28Z | 0 | 0 | 090000648447e9b0 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref